Renal Failure and the Concomitant Derangement of Micronutrient Metabolism

Rocco M Makoff R : Appropriate vitamin therapy for dialysis patients. Sem Dial 10: 272–277, 1997

Stein G Sperschneider S Koppe S : Vitamin levels in chronic renal failure and need for supplementation. Blood Purif 3: 52–62, 1985

Gallieni M Brancaccio D Cozzolino M : Trace elements in renal failure: Are they clinically important? Nephrol Dial Transplant 11: 1232–1235, 1996

Waxman S Corcino JJ Herbert V : Drugs, toxins and dietary amino acids affecting vitamin B₁₂ or folic acid absorption or utilization. Am J Med 48: 599–608, 1970

Stone WJ Warnock LG Wagner C : Vitamin B₆ deficiency in uremia. Am J Clin Nutr 28: 950–957, 1975

Drueke TB : Resistance to recombinant human erythropoietin in hemodialysis patients. Am J Nephrol 10(Supp2): 34–39, 1990

Pronai W Riegler-Keil M Silberbauer K : Folic acid supplementation improves erythropoietin response. Nephron 71: 395–400, 1995

Makoff R Dwyer J Rocco MV : Folic acid, pyridoxine, cobalamin and homocysteine and their relationship to cardiovascular disease in end-stage renal disease. J Renal Nutri 6: 2–11, 1996

Bostom AG Culleton BF : Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol; 10: 1–10, 1999

McCully KS : Vascular pathology of homocysteinemia: Implications for pathogenesis of arteriosclerosis. Am J Pathol 56: 111–128, 1969

Steiner A : The effect of choline on the production of experimental atherosclerosis in rabbits. Proc Soc Exp Biol Med 38: 231–233, 1938

Hartoff WE Ridout JH Sellers EA : Atheromatous changes in aorta, carotid and coronary arteries of choline deficient Rats. Proc Soc Exp Biol Med 81: 384–393, 1952

Ueland PM Refsum H Brattstrom L : Plasma homocysteine and cardiovascular disease. IN Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function, Francis RB Jr (ed). Dekker, New York, 1992, pp 183–236

Smolin LA Benevenga NGH : Accumulation of homocysteine in vitamin B6 deficiency: A model for the study of cystathionine β synthase deficiency. J Nutri 112: 1264–1272, 1982

Peterson JC Spence JD : Vitamins and the progression of atherosclerosis in hyperhomocysteinemia. Lancet 351: 263, 1998

Norris SH Kurtzman NA : Minimizing anemia in the chronic hemodiaysis patient. Int Artif Organs 9: 199–208, 1986

Kopple JD Mercurio K Blumenkrantz MJ : Daily requirement for pyridoxine supplementation in chronic renal failure. Kidney Int 19: 694–704, 1981

Ross EA Shah GM Reynolds RD : Vitamin B₆ requirements of patients on chronic periotoneal dialysis. Kidney Int 36: 702–706, 1989

Author name, XX: Even a mild lack of B₁₂ could hurt seniors: Tufts Nutri Lett 9: 11, 1992

House AA Donnelly JG : Effect of multivitamins on plasma homocysteine and folate levels in patients on hemodialysis. ASAIO J 45: 94–97, 1999

Hida MM Jufii H Satoh T : Vitamin and mineral status in chronic renal failure—The effect of protein restriction. Nippon Jinzo Gakkai Shi 36: 740–745, 1994

Pietrazak I : Vitamin disturbances in chronic renal insufficiency. I. Water soluble vitamins. Przegl Lek 52: 522–525, 1995

Jung U Helbich-Endermann M Bitsch R : Are patients with chronic renal failure (CRF) deficient in biotin and is regular biotin supplementation required? Z Ernahrungswiss 37: 363–367, 1998

Rocco MV Poole D Poindexter P : Intake of vitamins and minerals in stable hemodialysis patients as determined by nine-day food records. J Renal Nutri 7: 17–24, 1997

Allman MA Truswell AS Tiller DJ : Vitamin supplementation of patients receiving hemodialysis. Med J Aust 150: 130–133, 1989

Tomson CRV Channon SM Parkinson IS : Correction of sub-clinical ascorbate deficiency in patients receiving dialysis: Effects on plasma oxalate, serum cholesterol and capillary fragility. Clin Chem Acta 180: 255–264, 1989

Costello JF Sadovnic MJ Cottington EM : Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal. J Am Soc Nephrol 1: 1289–1298, 1991

Thompson CS Weinman EJ : The secondary oxalosis of renal failure. Sem in Dial: 94–99, 1988

Pru C Eaton J Kjellstrand C : Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients. Nephron 39: 112–116, 1985

Shah GM Ross EAL Sabo A : Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients. Am J Kid Dis 20: 42–49, 1992

Yatzidis H Digenis P Fountas P : Hypervitaminosis A accompanying advanced chronic renal failure. Brit Med J 3: 352–353, 1975

Muth I : Implications of Hypervitaminosis A in chronic renal failure. J Renal Nutri 1: 2–8, 1991

Fishbane S Frei GL Finger M : Hypervitaminosis A in two hemodialysis patients. Am J Kidney Dis 25: 346–349, 1995

Gleghorn E Eisenberg L Hack S : Observations of vitamin A toxicity in three patients with renal failure receiving parenteral alimentation. Am J Clin Nutri 44: 107–112, 1986

Duffy TP : Remembering the ABC's. New Engl J Med 330: 994–996, 1994

Pastor MC Sierra C Bonal J : Serum and erythrocyte tocopherol in uremic patients: Effect of hemodialysis versus peritoneal dialysis. Am J Nephrol 13: 238–243, 1993

Cohen JD Vilijoen M Clifford D : Plasma vitamin E levels in a chronically hemolyzing group of dialysis patients. Clin Nephrol 25: 42–47, 1986

Ono K : Effects of large dose vitamin E supplementation on anemia in hemodialysis patients. Nephron 40: 440–445, 1985

Roca AO Jarjoura D Blend D : Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO J 38: M481–M485, 1992

Roberts HJ : Perspective on vitamin E as therapy. JAMA 246: 129–131, 1981

Suttie JW : Vitamin K. IN Handbook of Vitamins (2nd ed.), MacHlin LJ , (ed). Marcel Dekker, New York, 1991, pp 145–194

Fukagawa M Kitaoka M Fukada N : Pathogenesis and mangement of parathyroid hyperplasia in chronic renal failure: Role of calcitriol. Min Electro Metab 21: 97–100, 1995

Martin KJ Gonzalez EA Gellens M : 19-Nor-1-25 Dihydroxyvitamin D₂ (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis. JASN 9: 1427–1432, 1998

Kopple JD Swenseid ME : Nutrition in patients undergoing maintenance hemodialysis. Kid Int 8(Suppl2): 79–84, 1975

Prasad AS Oberleas D : Binding of zinc to amino acids and serum proteins in vitro. J Lab Clin Med 76: 416–425, 1970

Flynn A Pories WJ Strain WH : Rapid serum-zinc depletion associated with corticosteroid therapy. Lancet ii: 1169–1172, 1971

Prasad AS Schoomacker EB Ortega J : Zinc deficiency in sickle cell disease. Clin Chem 21: 582–587, 1975

Prasad AS Halsted JA Nadimi M : Syndrome of iron deficiency anemia, hepatosplenomegaly, hypogonadism, dwarfism, and geophagia. Am J Med 31: 532–546, 1961

Henkin RI Scheichter PF Friedewald WT : A double-blind study of the effects of zinc sulfate on taste and smell function. Am J Med Sci. 272: 285–299, 1976

Mahajan SK Bowersox EM Rye DL : Factors underlying abnormal zinc metabolism in uremia. Kid Int 36(Suppl. 27): S269–S273, 1989

Antoniou LD Shalhour RJ Sudhakar T : Reversal of uraemic impotence by zinc. Lancet: 895–898, October 1977

Mahajan SK Abbasi AA Prasad AS : Effect of oral zinc therapy on gonadal function in hemodialysis patients. Ann Int Med Sep 97: 357–361, 1982

Mahajan SK Prasad AS Lambujon J : Improvement of uremic hypogeusia by zinc: A double-blind study. Am J Clin Nutr 33: 1517–1521, 1980

Atkin-Thor E Goddard BW O'Nion J : Hypogeusia and zinc depletion in chronic dialysis patients. Am J Clin Nutr 31: 1948–1951, 1978

Zetin M Stone RA : Effects of zinc in chronic hemodialysis. Clin Nephr 13: 20–25, 1980

Brook AC Ward MK Cook DB : Absence of a therapeutic effect of zinc in the sexual dysfunction of haemodialysed patients. Lancet 20: 618–620, 1980

Vreman HJ Venter C Leegwater J : Taste, smell and zinc metabolism in patients with chronic renal failure. Nephron 26: 163–170, 1980

Song MK Adham NF : Determination of native zinc content of alpha-2-macroglobulin in normal, hyperzincemie and hypozincemic sera by sucrose density gradient centrifugation. Clin Chim Acta 99: 13–21, 1979

Dasgupta A Peng Y : Dialyzability and binding of digoxin-like immunoreactive factors (DLIF) with serum macromolecules in uremic patients on hemodialysis. Life Sci 49: 1603–1609, 1991

Zumkley H Bertram HP Vetter H : Zinc concentrations in plasma and erythrocytes in digitalized patients. Klin Wochenschr 59: 1345–1347

Keyou G Zue A Bai J : Keshan disease—An endemic cardiomyopathy in China. Virchows Arch (Pathol Anat) 401: 1–15, 1983

Fleming CR Lie JT McCall JT : Selenium deficiency and fatal cardiomyopathy in a patient on home parenteral nutrition. Gastroenterol 83: 689–693, 1982

Leung A Henderson I Fell G : Selenium deficiency in chronic uraemia and dialysis. Proc EDTA-ERA 22: 1134–1138, 1985

Kostakopoulos A Kotsalos A Alexopoulos J : Serum selenium levels in healthy adults and its changes in chronic renal failure. Int Urol Nephrol 22: 397–401, 1990

Girelli D Olivieri O Stanzial AM : Low platelet glutathione peroxidase activity and serum selenium concentration in patients with chronic renal failure: Relations to dialysis treatments, diet and cardiovascular complications. Clin Sci (Colch) 84: 611–617, 1993

Napolitano G Bonomini M Bomba G : Thyroid function and plasma selenium in chronic uremic patients on hemodialysis treatment. Biol Trace Elem Res 55: 221–230, 1996

Bonomini M Forster S Manfrini V : Geographic factors and plasma selenium in uremia and dialysis. Nephron 72: 197–204, 1996

Milly K Wit L Diskin C : Selenium in renal failure patients. Nephron 61: 139–144, 1992

Alfrey AC LeGendre GR Kaehny WD : The dialysis encephalopathy syndrome: Possible aluminum intoxication. N Eng J Med 294: 184–188, 1976

Kaehny WD Alfrey AC Holman RE : Aluminum transfer during hemodialysis. Kid Int 12: 361–365, 1977

Parkinson IS Ward MK Feest TG : Fracturing dialysis osteodystrophy and dialysis encephalopathy: An epidemiological survey. Lancet i: 406–409, 1979

Cournot-Witmer G Zingraff J Plachot JJ : Aluminum localization in bone from hemodialyzed patients: Relationship to matrix mineralization. Kid Int 20: 375–385, 1981

Hodsmen AB Sherrard DJ Alfrey AC : Bone aluminum and histomorphometric features of renal osteodystrophy. J Clin Endocrinol Metab 54: 539–546, 192

Sherrard DJ : Aplastic bone: A nondisease of medical progress. Adv Ren Replace Ther 2: 20–23, 1995

Touam M Martinez F Lacour B : Aluminum-induced, reversible microcytic anemia in chronic renal failure: Clinical and experimental studies. Clin Nephrol 19: 295–298, 1983

Alfrey AC : Aluminum and renal disease. Contrib Nephrol 102: 110–124, 1993

King S Wills M Savory J : Serum binding of aluminum. Res Commun Chem Pathol Pharmacol 26: 161–169, 1979

Khalil-Manesh F Agness C Gonick HC : Aluminum-binding protein in dialysis dementia. I. Characterization in plasma by gel chromatography and electrophoresis. Nephron 52: 323–328, 1989

Khalil-Manesh F Agness C Gonick HC : Aluminum-binding protein in dialysis dementia. II. Characterization in plasma by ultrafiltration. Nephron 52: 329–333, 1989

Milliner DS Nebeker HG Ott SM : Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy. Ann Int Med 101: 775–780, 1984

Boelaert JR Fenves AZ Coburn JW : Deferoxamine therapy and mucormycosis in dialysis patients: Report of an international registry. Am J Kid Dis 18: 660–667, 1991

deLocht M Boelaert JR Schneider YJ : Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus. Biochem Pharmacol 47: 1843–1850, 1994

Eijgenraam FJ Donckerwolcke RA : Treatment of iron overload in children and adolescents on chronic haemodialysis. Eur J Pediatr 149: 359–362, 1990

Hughes RT Smith T Hesp R : Regulation of iron absorption in iron loaded subjects with end stage renal disease: Effects of treatment with recombinant human erythropoietin and reduction of iron stores. Br J Haemaatol 82: 445–454, 1992

Barany P ERiksson LC Hultcrantz R : Serum ferritin and tissue iron in anemic dialysis patients. Miner Electrolyte Metab 23: 273–276, 1997

DeMarchi S Cecchin E : Hepatic computed tomography for monitoring the iron status of haemodialysis patients with haemosiderosis treated with recombinant human erythropoietin. Clin Sci (Colch) 81: 113–121, 1991

el-Reshaid K Seshadri MS Hourani H : Endocrine abnormalities in hemodialysis patients with iron overload: Reversal with iron depletion. Nutr 11(Suppl): 521–526, 1995

Van de Vyver FL Visser WJ D'Haese PC : Iron overload and bone disease in chronic dialysis patients. Nephrol Dial Transplant 5: 781–787, 1990

Parry R Plowman D Delves HT : Silicon and aluminium interactions in haemodialysis patients. Nephrol Dial Transplant 13: 1759–1762, 1998

Hosokawa S Yoshida O : Silicon level in rats with chronic renal failure produced by 5/6 nephrectomy. Nephron 69: 301–304, 1995

Saldanha LF Gonick HC Rodriguez HJ : Silicon-related syndrome in dialysis patients. Nephron 77: 48–56, 1997

Hershey CO Ricanati ES Hershey LA Silicon as a potential uremic neurotoxin: Trace element analysis in patients with renal failure. Neurology 33: 786–791, 1983

Berlyne G Dudek E Adler AJ : Silicon metabolism: The basic facts in renal failure. Kid Int 28(Suppl 17): S175–S177, 1983

Gitelman HJ Alderman FR Perry SJ : Silicon accumulation in dialysis patients. Am J Kid Dis 19: 140–143, 1992

Dobbie JW Smith MB : Urinary and serum silicon in normal and uraemic individuals. Ciba Found Symp 121: 194–213, 1986

Hosokawa S Morinaga M Nishitani H : Silicon in chronic hemodialysis patients. Trans Am Soc Artif Intern Organs XXXII: 260–264, 1987

Van de Vyver FL D'Haese PC Visser WJ : Bone lead in dialysis patients. Kid Int 33: 601–607, 1988

Hu H : Bone lead as a new biologic marker of lead dose: Recent findings and implications for public health. Environ Health Perspectives 106(Suppl 4): 961–967, 1998

Wedeen RP : Bone lead, hypertension, and lead nephropathy. Environ Health Perspect 78: 57–60, 1988

Adachi JD Arlen D Webber CE : Is there any association between the presence of bone disease and cumulative exposure to lead? Calcif Tissue Int 63: 429–432, 1998

Gonick HC Alexander GV : Trace element abnormalities in chronic uremia. NIAMDD Report #AK-3-6-2212-F, 1977

Kessler M Durand PY Hestin D : Elevated body lead burden from drinking water in end-stage chronic renal failure. Nephrol Dial Transplant 10: 1648–1653, 1995

Sondheimer JH Mahajan SK Rye DL : Elevated plasma copper in chronic renal failure. Am J Clin Nutr 47: 896–899, 1988

Barbour BH Bischel M Abrams DE : Copper accumulation in patients undergoing chronic hemodialysis. The role of cuprophan. Nephron 8: 455–462, 1971

Chugh KS Sharma BK Singhai PC : Acute renal failure following copper sulphate intoxication. Postgrad Med J 53: 18–23, 1977